Biotech investors
Updated 16 Nov 2026
Venture funds
50 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | SOSV SOSV provides early-stage funding for healthcare and environmental technologies, with recent investments including Opentrons and Prolific Machines. Princeton, United States |
Hardware, Artificial intelligence | Seed, Early stage venture | 41% | 17 |
| 2 | SOSV SF & NY (Fka IndieBio) SOSV SF & NY, formerly IndieBio, supports deep tech founders, with recent investments including Prolific Machines and heXem bio. San Francisco, United States |
Biotech, Health care | Seed, Early stage venture | 3% | 14 |
| 3 | Qiming Venture Partners Qiming Venture Partners invests in technology, consumer and healthcare companies at early and growth stages, with recent investments including Houmo.AI and AusperBio. Shanghai, China |
Health care, Artificial intelligence | Seed, Early stage venture, Late stage venture | 50% | 11 |
| 4 | Innovate UK Innovate UK runs funding competitions for businesses and research organizations in emerging technologies, with recent awardees including Ryft and Concretene. Swindon, United Kingdom |
Artificial intelligence, Health care | 75% | 8 | |
| 5 | Alumni Ventures Alumni Ventures offers accredited investors diversified startup portfolios, with recent investments including Coframe and Ocient. Manchester, United States |
Artificial intelligence, Fintech | Seed, Early stage venture, Late stage venture | 1% | 7 |
| 6 | Khosla Ventures Khosla Ventures backs AI, sustainability, health and frontier technologies, with recent investments including Opentrons and Ramp. Menlo Park, United States |
Artificial intelligence, Health care | Seed, Early stage venture, Late stage venture | 39% | 7 |
| 7 | Legend Capital Legend Capital invests in China, with recent investments including Infinigence and Sinsegye. Beijing, China |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 42% | 7 |
| 8 | Alexandria Venture Investments Alexandria Venture Investments invests in real estate technology and healthcare, with recent investments including Lycia Therapeutics and Aspen Neuroscience. Pasadena, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 7% | 5 |
| 9 | HTGF (High-Tech Gruenderfonds) HTGF invests across various sectors, with recent investments including Rabot Energy and CereGate. Bonn, Germany |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 28% | 5 |
| 10 | ANRI ANRI is a Japanese venture firm mainly investing in seed and early-stage startups, recently backing Craif and LAMP Japan. Tokyo, Japan |
Health care, Artificial intelligence | Seed, Early stage venture, Late stage venture | 26% | 4 |
| 11 | Mission BioCapital Mission BioCapital invests in early-stage life science companies, with recent investments including Circle Pharma and Cloverleaf Bio. Cambridge, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 20% | 4 |
| 12 | BioVenture BioVenture offers early and growth stage investment, with recent investments including AusperBio and Degron Therapeutics. Suzhou, China |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 33% | 4 |
| 13 | Bristol-Myers Squibb Bristol-Myers Squibb develops and sells pharmaceuticals, with recent investments including BigHat Biosciences and Ratio Therapeutics. New York, United States |
Biotech, Health care | Early stage venture | 30% | 4 |
| 14 | Gaingels Gaingels funds startups and supports diversity and inclusion in entrepreneurship, with recent investments including Delix Therapeutics and Ocient. Burlington, United States |
Artificial intelligence, Fintech | Seed, Early stage venture, Late stage venture | 1% | 4 |
| 15 | Google Ventures Google Ventures provides seed through growth-stage funding to technology companies, with recent investments including Harvey and SambaNova. San Francisco, United States |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 29% | 4 |
| 16 | K2VC K2VC invests in early stage technology startups, including Shexu Technology and Startorus Fusion. Beijing, China |
Commerce, Fintech | Seed, Early stage venture | 22% | 4 |
| 17 | Novo Holdings Novo Holdings invests in life science companies, with recent companies including Claris Biotherapeutics and Windward Bio. Hellerup, Denmark |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 36% | 4 |
| 18 | Sofinnova Partners Sofinnova Partners invests in life sciences from seed to later stage, including T-Therapeutics, Mironid and DISCO Pharmaceuticals. Paris, France |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 44% | 4 |
| 19 | ARCH Venture Partners ARCH Venture Partners focuses on life science discoveries to prevent, detect and cure disease, with recent companies including Moonwalk Biosciences and Mirador Therapeutics. Chicago, United States |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 27% | 3 |
| 20 | Gaorong Capital Gaorong Capital focuses on TMT investments including AI and frontier technologies, including BioGeometry and Raysolve. Wangjing, China |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 29% | 3 |
| 21 | BlueYard Capital BlueYard Capital invests in founders with ideas that decentralize markets, with recent investments in Castelion and Cryptio. Berlin, Germany |
Fintech, Biotech | Seed, Early stage venture | 41% | 3 |
| 22 | Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund invests in therapeutic approaches and technologies, with recent investments in smartbax and Brainomix. Ingelheim Am Rhein, Germany |
Biotech, Health care | Seed, Early stage venture | 47% | 3 |
| 23 | Conscience VC Conscience VC invests in science, with recent companies Tiny Health and Integrated Biosciences. Austin, United States |
Health care, Biotech | Seed, Early stage venture | 8% | 3 |
| 24 | Fifty Years Fifty Years backs entrepreneurs solving the world's biggest problems, recently investing in Multiply Labs and Aalo Atomics. San Francisco, United States |
Artificial intelligence, Health care | Seed, Early stage venture, Late stage venture | 19% | 3 |
| 25 | Global Brain Corporation Global Brain Corporation invests from seed or early stage to pre-IPO, with recent investments including Newmo and Zafrens. Tokyo, Japan |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 31% | 3 |
| 26 | Haitang Fund Haitang Fund is a venture fund founded by Tianjin University alumni entrepreneurs, with recent investments in Zhonghe Gene and Xingsai Bio. Nankai, China |
Biotech, Health care | Early stage venture | 30% | 3 |
| 27 | Hummingbird Ventures Hummingbird Ventures backs outlier founders globally, recently investing in Etched and Lovable. Brussels, Belgium |
Artificial intelligence, Biotech | Seed, Early stage venture | 28% | 3 |
| 28 | IDG Capital IDG Capital funds early- to growth-stage technology companies, with recent investments including Zero Zero Robotics and XPENG Robotics. Beijing, China |
Hardware, Fintech | Seed, Early stage venture, Late stage venture | 36% | 3 |
| 29 | Joyance Partners Joyance Partners invests in companies using science and technology to cultivate joy, with recent investments including Mosh and Sparxell. San Francisco, United States |
Health care, Biotech | Seed, Early stage venture | 8% | 3 |
| 30 | Matrix Partners China Matrix Partners China builds long-term relationships with entrepreneurs in China, with recent investments including Houmo.AI and Astribot. Beijing, China |
Artificial intelligence, Hardware | Early stage venture | 34% | 3 |
| 31 | Med-Fine Capital Med-Fine Capital focuses on healthcare and bio-science, with recent investments including Artivila Therapeutics and Phrontline Biopharma. Shanghai, China |
Health care, Biotech | Early stage venture | 30% | 3 |
| 32 | Modi Ventures Modi Ventures focuses on investing into the next frontier, and recently backed Tiny Health and Latus Bio. Houston, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 14% | 3 |
| 33 | Pfizer Pfizer is a biopharmaceutical company developing medicines and vaccines, with recent companies including Circle Pharma, CellCentric and FoRx Therapeutics. New York, United States |
Biotech, Health care | 40% | 3 | |
| 34 | Shenzhen Capital Group Shenzhen Capital Group focuses on cultivating national industries and national brands, with recent investments including SAGE Intelligent and Chasing Innovation. Nanshan, China |
Hardware, Health care | Seed, Early stage venture, Late stage venture | 40% | 3 |
| 35 | Shunwei Capital Shunwei Capital focuses on China's internet industry at early to mid stages, with recent companies including SAGE Intelligent and Hooke Instruments. Beijing, China |
Hardware, Commerce | Seed, Early stage venture, Late stage venture | 31% | 3 |
| 36 | The Column Group The Column Group is a venture firm dedicated to biotechnology companies, with recent companies including Circle Pharma, InduPro and Atavistik Bio. San Francisco, United States |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 39% | 3 |
| 37 | 2048 Ventures 2048 Ventures is a thesis-driven venture firm, recently backing TwoStep Therapeutics and Genius AI. New York, United States |
Artificial intelligence, Fintech | Seed, Early stage venture | 67% | 2 |
| 38 | 8VC 8VC structures capital deployments for technology companies, with recent investments including Sirona Medical and BigHat Biosciences. Austin, United States |
Artificial intelligence, Fintech | Seed, Early stage venture, Late stage venture | 30% | 2 |
| 39 | Alpha Wave Global Alpha Wave Global operates across private equity, private credit, public markets and insurance, with recent investments in Moonwalk Biosciences and Cour Pharmaceuticals Development. Miami, United States |
Fintech, Artificial intelligence | Seed, Early stage venture, Late stage venture | 54% | 2 |
| 40 | Artis Ventures Artis Ventures invests in companies at the intersection of technology, health and biology, including Delix Therapeutics and Ozlo Sleep. San Francisco, United States |
Health care, Hardware | Seed, Early stage venture, Late stage venture | 35% | 2 |
| 41 | Astanor Ventures Astanor Ventures backs entrepreneurs regenerating food, the blue ocean economy and agriculture, with recent companies BioFluff and Standing Ovation. Luxembourg, Belgium |
Artificial intelligence, Biotech | Seed, Early stage venture, Late stage venture | 55% | 2 |
| 42 | BioTrack Capital BioTrack Capital invests in life sciences, healthcare technology and biotechnology, with recent companies including Yuce Biotechnology and Rigen Biotech. Shanghai, China |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 33% | 2 |
| 43 | BoxGroup BoxGroup invests in early-stage technology companies, with recent investments including Nominal and Northwood Space. New York, United States |
Artificial intelligence, Fintech | Seed, Early stage venture | 5% | 2 |
| 44 | Boyuan Capital Boyuan Capital operates as an investment platform, with recent companies Yuce Biotechnology and Rigen Biotech. Shanghai, China |
Health care, Biotech | Late stage venture | 38% | 2 |
| 45 | Breakthrough Energy Ventures Breakthrough Energy Ventures targets reliable, affordable power without climate impact, recently backing Type One Energy and Antora Energy. Paris, France |
Energy, Artificial intelligence | Seed, Early stage venture, Late stage venture | 43% | 2 |
| 46 | Builders VC Builders VC invests where technology meets new business models to modernize antiquated industries, including Clay and Pie Systems. San Francisco, United States |
Artificial intelligence, Health care | Early stage venture | 34% | 2 |
| 47 | Cambridge Innovation Capital Cambridge Innovation Capital invests in early-stage deep technology and life sciences companies, including T-Therapeutics and Microbiotica. Cambridge, United Kingdom |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 36% | 2 |
| 48 | Casdin Capital Casdin Capital does fundamental research investing in life sciences and healthcare, with recent companies Multiply Labs and Thyme Care. New York, United States |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 15% | 2 |
| 49 | Chengdu Science and Technology Venture Capital Chengdu Science and Technology Venture Capital is a venture firm with recent companies including Kunteng Tech, QL Biopharma and New Radiomedicine Technology. Chengdu, China |
Biotech, Health care | Early stage venture, Late stage venture | 36% | 2 |
| 50 | Coral Capital Coral Capital invests at the seed stage with a full-service approach, with recent companies including Facilo, Dioseve and Cosomil. Tokyo, Japan |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 29% | 2 |
Table 1. Biotech investors: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Y Combinator | Startup accelerator | Mountain View, United States | •••@ycombinator.com | (415) ••• |
| HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | •••@htgf.de | +49 22••• |
| SOSV | Venture capital firm | Princeton, United States | •••@sosv.com | |
| National Science Foundation | Entrepreneurship program | Alexandria, United States | •••@nsf.gov | (703) ••• |
| Venture Kick | Startup incubator | Schlieren, Switzerland | •••@venturekick.ch | +41 (2••• |
| RA Capital Management | Startup incubator | Boston, United States | •••@racap.com | 617.77••• |
| SOSV SF & NY (Fka IndieBio) | Venture capital firm | San Francisco, United States | •••@sosv.com | |
| Alumni Ventures | Angel group | Manchester, United States | •••@av.vc | +1 603••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
| Firm | Person | Title | Verified email | |
|---|---|---|---|---|
| Y Combinator | G••• A••• | General Partner | g•••@ycombinator.com | In the CSV |
| SOSV | O••• R••• | Managing General Partner | o•••@sosv.com | In the CSV |
| RA Capital Management | P••• K••• | Managing Partner | p•••@racap.com | In the CSV |
| OrbiMed | W••• P••• | Managing Director | p•••@orbimed.com | In the CSV |
| Techstars | A••• B••• | Managing Director NYC Programs | a•••@techstars.com | In the CSV |
5 verified partner contact rows from organizations on this list, names and emails masked.
- 704 of the 993 biotech investors have a published email address, 639 a phone number and 972 a website.
- Y Combinator has the most recorded investments, 8,719, 3,692 of them as lead investor.
- 722 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Y Combinator is an investor in 225 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Sciphage's $107K seed round on 11 November 2026.
- Software is the most common sector across their 30,430 portfolio companies (77%).
- Early stage venture is the most common investment stage, recorded for 896 of them (90%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors
30 of 993, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Y Combinator | Startup accelerator | Mountain View, United States | Artificial intelligence, Fintech | Kalshi, Opentrons, Reflex | 225 | 8,719 | 3,692 | 783 | •••@ycombinator.com | (415) ••• | In the CSV |
| 2 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | Biotech, Health care | Rabot Energy, CereGate, syte | 17 | 1,026 | 290 | 136 | •••@htgf.de | +49 22••• | In the CSV |
| 3 | SOSV | Venture capital firm | Princeton, United States | Hardware, Artificial intelligence | Opentrons, live2.ai, Prolific Machines | 30 | 2,865 | 1,185 | 98 | •••@sosv.com | In the CSV | |
| 4 | National Science Foundation | Entrepreneurship program, Government investment office | Alexandria, United States | Hardware, Artificial intelligence | Emvolon, Xona, MuukTest | 36 | 4,642 | 4,419 | 269 | •••@nsf.gov | (703) ••• | In the CSV |
| 5 | Venture Kick | Startup incubator | Schlieren, Switzerland | Health care, Biotech | UniSieve, Cotierra, Jaipur Robotics | 13 | 1,459 | 1,342 | 82 | •••@venturekick.ch | +41 (2••• | In the CSV |
| 6 | RA Capital Management | Startup incubator, Private equity firm | Boston, United States | Health care, Biotech | Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics | 9 | 544 | 183 | 243 | •••@racap.com | 617.77••• | In the CSV |
| 7 | SOSV SF & NY (Fka IndieBio) | Venture capital firm | San Francisco, United States | Biotech, Health care | Prolific Machines, heXem bio, BryoSphere | 17 | 596 | 17 | 12 | •••@sosv.com | In the CSV | |
| 8 | Alumni Ventures | Angel group, Micro VC fund | Manchester, United States | Artificial intelligence, Fintech | Coframe, Ocient, Formic | 67 | 2,424 | 32 | 263 | •••@av.vc | +1 603••• | In the CSV |
| 9 | OrbiMed | Private equity firm | New York, United States | Health care, Biotech | Triveni Bio, Windward Bio, Terremoto Biosciences | 8 | 810 | 276 | 304 | +1 (21••• | In the CSV | |
| 10 | MassChallenge | Startup accelerator | Boston, United States | Artificial intelligence, Health care | HELIOS, DrizzleX, ScribeUp | 26 | 3,225 | 1,037 | 267 | •••@masschallenge.org | In the CSV | |
| 11 | Techstars | Startup accelerator | New York, United States | Artificial intelligence, Fintech | Zipline International, Intuitivo, MuukTest | 67 | 6,842 | 3,391 | 638 | •••@techstars.com | +1 303••• | In the CSV |
| 12 | Innovate UK | Entrepreneurship program, Venture capital firm | Swindon, United Kingdom | Artificial intelligence, Health care | Bioliberty, Concretene, Doctoria LTD | 27 | 1,307 | 976 | 84 | •••@innovateuk.ukri.org | In the CSV | |
| 13 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | Biotech, Health care | TwoStep Therapeutics, Lycia Therapeutics, Triveni Bio | 5 | 318 | 21 | 68 | •••@gmail.com | 626.57••• | In the CSV |
| 14 | Plug and Play | Startup accelerator, Co-working space | Sunnyvale, United States | Artificial intelligence, Fintech | Opsin, Helical Fusion, Reco | 51 | 2,592 | 352 | 230 | •••@pnptc.com | +1 408••• | In the CSV |
| 15 | Bpifrance | Government investment office, Investment bank | Maisons-alfort, France | Artificial intelligence, Hardware | WORMSENSING, CarbonFarm Technology, Archeon | 19 | 1,680 | 454 | 214 | •••@bpifrance.fr | +33 (0••• | In the CSV |
| 16 | Qiming Venture Partners | Venture capital firm | Shanghai, China | Health care, Artificial intelligence | Houmo.AI, Infinigence, AusperBio | 21 | 1,106 | 555 | 104 | •••@qimingvc.com | (+86) ••• | In the CSV |
| 17 | European Innovation Council | Startup accelerator | Brussels, Belgium | Hardware, Health care | Onego Bio, Quantrol Ox, Cellbox Solutions | 17 | 1,271 | 921 | 48 | In the CSV | ||
| 18 | Creative Destruction Lab | Entrepreneurship program, University program | Toronto, Canada | Artificial intelligence, Hardware | Specific Biologics, Circuit Mind, Xona | 21 | 788 | 215 | 87 | •••@creativedestructionlab.com | (404) ••• | In the CSV |
| 19 | Forbion Capital Partners | Private equity firm, Venture capital firm | Naarden, The Netherlands | Biotech, Health care | Kynexis, Beacon Therapeutics | 2 | 188 | 93 | 54 | •••@forbion.com | +31 35••• | In the CSV |
| 20 | ARCH Venture Partners | Venture capital firm | Chicago, United States | Health care, Biotech | Moonwalk Biosciences, Moleculent, Mirador Therapeutics | 3 | 535 | 147 | 121 | •••@archventure.com | 773-38••• | In the CSV |
| 21 | Novo Holdings | Corporate venture arm, Venture capital firm | Hellerup, Denmark | Health care, Biotech | Claris Biotherapeutics, Windward Bio, Terremoto Biosciences | 5 | 417 | 150 | 115 | •••@novo.dk | 45 35 ••• | In the CSV |
| 22 | KfW | Government investment office, Investment bank | Frankfurt, Germany | Biotech, Health care | CryoTherapeutics, Vectoflow, HelloDuty | 198 | 29 | 56 | •••@kfw.de | 49 69 ••• | In the CSV | |
| 23 | Andreessen Horowitz | Venture capital firm | Menlo Park, United States | Artificial intelligence, Fintech | Shield AI, Zipline International, Northwood Space | 49 | 2,041 | 916 | 311 | •••@a16z.com | (650) ••• | In the CSV |
| 24 | Khosla Ventures | Venture capital firm | Menlo Park, United States | Artificial intelligence, Health care | Coframe, Opentrons, Even Healthcare | 25 | 1,479 | 575 | 208 | •••@khoslaventures.com | +1 650••• | In the CSV |
| 25 | Google Ventures | Corporate venture arm, Venture capital firm | San Francisco, United States | Artificial intelligence, Hardware | Snorkel AI, Thatch, Harvey | 20 | 1,331 | 392 | 304 | In the CSV | ||
| 26 | National Institutes of Health | Entrepreneurship program | Bethesda, United States | Health care, Biotech | Ramona, Talus Bio, Samay | 5 | 1,049 | 774 | 107 | •••@od.nih.gov | 301-49••• | In the CSV |
| 27 | Bristol-Myers Squibb | Venture capital firm | New York, United States | Biotech, Health care | BigHat Biosciences, Ratio Therapeutics, Cour Pharmaceuticals Development | 4 | 109 | 33 | 22 | (212)5••• | In the CSV | |
| 28 | Sofinnova Partners | Venture capital firm | Paris, France | Biotech, Health care | T-Therapeutics, Mironid, Bon Vivant | 5 | 373 | 164 | 76 | •••@sofinnovapartners.com | +33 (0••• | In the CSV |
| 29 | Pioneer Fund | Startup accelerator | Toronto, Canada | Artificial intelligence, Fintech | Vera Health, Ultra, Talus Bio | 35 | 860 | 12 | 34 | •••@pioneerfund.vc | In the CSV | |
| 30 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | Health care, Biotech | FoRx Therapeutics | 1 | 198 | 74 | 55 | •••@lspvc.com | +31 20••• | In the CSV |
Table 2. Biotech investors: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 993.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Y Combinator | Mountain View, United States | 225 | 3,060 | Kalshi, Opentrons, Reflex |
| 2 | Alumni Ventures | Manchester, United States | 67 | 696 | Coframe, Ocient, Formic |
| 3 | Techstars | New York, United States | 67 | 2,132 | Zipline International, Intuitivo, MuukTest |
| 4 | Plug and Play | Sunnyvale, United States | 51 | 740 | Opsin, Helical Fusion, Reco |
| 5 | Andreessen Horowitz | Menlo Park, United States | 49 | 462 | Shield AI, Zipline International, Northwood Space |
| 6 | Antler | Singapore | 44 | 831 | Futuriza, AirDodge AS, Satlyt |
| 7 | General Catalyst | San Francisco, United States | 38 | 344 | Nominal, Tractian, StockGro |
| 8 | National Science Foundation | Alexandria, United States | 36 | 244 | Emvolon, Xona, MuukTest |
| 9 | Pioneer Fund | Toronto, Canada | 35 | 290 | Vera Health, Ultra, Talus Bio |
| 10 | Sequoia Capital | Menlo Park, United States | 32 | 429 | Zipline International, Kalshi, Hex Technologies |
| 11 | Lightspeed Venture Partners | Menlo Park, United States | 31 | 378 | Casap, Supabase, Snorkel AI |
| 12 | SOSV | Princeton, United States | 30 | 356 | Opentrons, live2.ai, Prolific Machines |
| 13 | Tiger Global Management | New York, United States | 27 | 289 | Harbinger, Easol, Mach9 |
| 14 | 500 Global | Palo Alto, United States | 27 | 1,023 | Takenos, Daytona, Salary Hero |
| 15 | Innovate UK | Swindon, United Kingdom | 27 | 163 | Bioliberty, Concretene, Doctoria LTD |
Table 3. Biotech investors: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Sciphage | Sciphage develops natural functional alternatives that reduce the use of antibiotics. | Biotech | Bogotá, Colombia | Seed | $107K | 2026-11-11 | $107K | The Ganesha Lab | 11 to 50 | 2014 |
| Light Frame | Light Frame builds core banking and portfolio management technology for wealth managers. | Fintech | Providence, United States | Seed | $5.1M | 2026-11-10 | $6.8M | Half Court Ventures | 1 to 10 | 2024 |
| Nominal | Nominal develops software platforms that help hardware engineering teams test, monitor, and analyze operational data. | Software | Los Angeles, United States | Series C | $240.0M | 2026-11-09 | $422.5M | General Catalyst, Founders Fund, Lux Capital +2 | 251 to 500 | 2022 |
| Newmo | Newmo develops a ride-sharing platform that provides transportation to local communities and consumers. | Software | Minato, Japan | Series B | $131.5M | 2026-11-09 | $255.1M | Global Brain Corporation, SMBC Venture Capital, Mizuho Capital +1 | 51 to 100 | 2024 |
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston, United States | Series C | $100.0M | 2026-11-09 | $244.1M | RA Capital Management, Dolby Family Ventures, Artis Ventures +1 | 11 to 50 | 2019 |
| Huasaiboman Medical Cell Biology | Huasaiboman Medical Cell Biology provides new cell therapy technologies and solutions as a biotechnology company. | Biotech | Qingdao Shi, China | Series B | $30.0M | 2026-11-09 | $30.0M | ASBV | 11 to 50 | 2019 |
| Coframe | Coframe builds software that continuously improves websites and apps based on real-world performance data. | Artificial intelligence | San Francisco, United States | Series A | $25.0M | 2026-11-09 | $34.3M | Alumni Ventures, Khosla Ventures, Soma Capital | 11 to 50 | 2023 |
| Tushen Zhihe | Tushen Zhihe provides artificial intelligence protein design services. | Artificial intelligence | Minhang, China | Seed | $1.4M | 2026-11-09 | $1.5M | Wuxi Capital | 11 to 50 | 2023 |
| Shield AI Unicorn | Shield AI develops AI-powered systems that enhance safety for service members and civilians. | Artificial intelligence | San Diego, United States | Series H | $2.0B | 2026-11-05 | $6.1B | Andreessen Horowitz | 1,001 to 5,000 | 2015 |
| Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | South San Francisco, United States | Series I | $1.5B | 2026-11-05 | $3.6B | Fidelity, Techstars, Andreessen Horowitz +2 | 1,001 to 5,000 | 2011 |
Table 4. Biotech investors: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 23,399 | 77% |
| Artificial intelligence | 7,392 | 24% |
| Fintech | 5,057 | 17% |
| Hardware | 4,802 | 16% |
| Health care | 4,049 | 13% |
| Commerce | 3,333 | 11% |
| Biotech | 1,822 | 6% |
| Education | 1,577 | 5% |
| Cybersecurity | 1,400 | 5% |
| Energy | 663 | 2% |
Table 5. Biotech investors: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 896 | 90% |
| Seed investors | 753 | 76% |
| Late stage investors | 520 | 52% |
| Venture investors | 449 | 45% |
| Private equity investors | 177 | 18% |
| Post IPO investors | 134 | 13% |
| Convertible note investors | 111 | 11% |
| Debt investors | 92 | 9% |
Table 6. Biotech investors by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Investors | Share |
|---|---|---|
| United States | 441 | 44% |
| China | 124 | 12% |
| United Kingdom | 68 | 7% |
| Germany | 60 | 6% |
| Switzerland | 32 | 3% |
| Canada | 27 | 3% |
| France | 23 | 2% |
| South Korea | 23 | 2% |
| Belgium | 20 | 2% |
| Japan | 18 | 2% |
| The Netherlands | 14 | 1% |
| Singapore | 13 | 1% |
Table 7. Biotech investors by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 8. Biotech investors by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 76 | 8% |
| 2010s | 434 | 45% |
| 2000s | 229 | 24% |
| 1990s | 112 | 12% |
| 1980s | 45 | 5% |
| 1970s | 19 | 2% |
Table 9. Biotech investors by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies. On 16 November 2026 that is 993 investors.
- 704 rows carry an email address and 639 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 993 rows: 21 have no website and 5 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors are on the list?
- 993, in the file dated 16 November 2026. 722 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 704 of the 993 carry an email address in the download and 639 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 993 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV with 993 rows, 704 firm email addresses and 639 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 483 of the 704 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.